Abstract
Excretory/Secretory Products (ESPs) of the nematode Trichinella spiralis contain antitumor-active substances that inhibit tumor growth. Mature dendritic cells (DCs) play a critical role in the antitumor immunity of the organism. As pathogen-derived products, it ought to be discussed whether T. spiralis ESPs will reduce the antitumor effect of mature DCs from the host before it is applied to patients’ tumors. Therefore, the aim of this work was to evaluate the immunological effect of DCs stimulated by T. spiralis ESPs in H22 tumor-bearing mice. H22 tumor model mice in this study were randomly divided into four groups according to the treatment: PBS control group, ESP group, DCs group, and DCs stimulated with T. spiralis ESP (ESP+DCs group). The antitumor effect was evaluated by tumor inhibition rate and cytokine detection using ELISA. The results showed significant inhibition in tumor growth in the ESP+DCs, DCs and ESP groups when compared with the PBS control group (p < 0.01, p < 0.01, and p < 0.05, respectively). However, no significant difference was observed on tumor inhibition rates between the ESP+DCs and DCs groups. The decrease in IL-4, IL-6, and IL-10, and the increase in IFN-γ between the DCs and ESP+DCs groups were also not significant. Therefore, DCs stimulated by ESP did not reduce the antitumor effect of mature DCs, which demonstrated that the T. spiralis ESP would not affect the antitumor effect of mature DCs by modulating the immune response of the host, and that ESPs are safe in antitumor immunology when applied in a tumor model mice.
Highlights
As a zoonotic nematode and foodborne parasite, T. spiralis infection leads to the suppression of the host immune response [13]
muscle larvae (ML), ADs, and newborn larvae (NBL) Excretory/Secretory Products (ESPs) were used as T. spiralis antigens
The results obtained in this study indicated that T. spiralis antigens from all three life stages of the parasite contributed to the development and maintenance of Th2 response
Summary
Trichinella spiralis was recognized for the first time in 1977 as a nematode that can negatively influence tumor growth. A certain number of the studies available on the anti-tumor mechanism of T. spiralis focus on the immunomodulatory effects of its antigens. The immunomodulatory effect is based on the development and maintenance of Th2 response during T. spiralis infection and different from the anti-tumor immunomodulatory effects of mature dendritic cells (DCs) in the organism
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.